Page 3 - Indian Pharmaceuticals Industry

Shot in the arm: Pharma sales clock double-digit growth in February

Amid Coronavirus fears, sales of antibiotics, paracetamol, and respiratory drugs see a spike

Lincoln Pharma plans to foray into regulated markets, upgrades facility

The company has upgraded its manufacturing facility at Khatraj near Ahmedabad with Rs 30-crore investment

Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems

A significant share of this money will go into upgrading the Sugam portal - the e-governance solution for CDSCO.

Firms fear coronavirus outbreak in China may hit India's drug industry

The Department of Pharmaceuticals (DoP) last week constituted a high-level panel to assess its impact of the outbreak of the deadly virus in China on the supply of APIs in India

Patented and in-licensed drugs post robust growth in Indian market

See 13.9% growth on MAT basis as against 9.4% for other drugs

Prolonged coronavirus outbreak in China could hurt Indian pharma sector

China accounted for 67.56% of total imports of bulk drugs and drug intermediates in 2018-19 at $2,405.42 million.

Torrent Pharma Q3 result: PBT rises 16% to Rs 319 crore, revenue declines

US business down by 22% in third quarter, India revenues grow by 5%

Demand for chronic illness medicines rising faster than acute drugs: Report

Long-term treatments like diabetes, high blood pressure and lipid-lowering drugs are classified into the chronic category

FDA observations on Telangana plant a fresh headache for Aurobindo Pharma

The Telangana unit in question is an important one contributing about a fifth to US revenues

Indian pharma exports may hit $22 bn in the current financial year: Report

Policy decisions being taken by the Chinese government may align favourably to Indian pharma exporters

Top 10 biz headlines: Realty, exports boost this week, DDT may go & more

From govt readying a package to help boost exports and real estate to the Direct Taxes Code panel recommending abolishing of dividend distribution tax, here are the top business headlines on Wednesday

Unichem Laboratories gets USFDA nod to market pain management drug

Unichem said the product will be commercialised from its Ghaziabad, Uttar Pradesh, plant

Alembic Pharma gets US health regulator nod for ophthalmic solution

The company said it now has a total of 86 ANDA approvals from the USFDA

At 13%, domestic pharma sales witness double-digit growth in July

Volume growth in the domestic market had turned negative in the last two months but was a big growth driver in July

Finally, Indian pharmaceutical industry scores on compliance with USFDA

2018 saw remedial work finally bearing fruit

PharmEasy, Netmeds ad campaigns leave consumers confused about the message

Online pharmacies, flush with funds from investors, are sparing no effort to get their brands visibility in a crowded marketplace

R&D growth in pharma firms like Cipla, Dr Reddy's outpaces revenue growth

Domestic pharma majors are betting big on R&D to drive future growth

Govt set to block $1.3-bn Chinese pharma firm Fosun's takeover of Gland

CCEA, chaired by PM, to block Fosun Pharma's purchase of 86% in Gland Pharma

Indian pharma gets US FDA booster dose

Sees 45% jump in approvals for new drugs compared to Jan-July period of last year

Time for pharma to make acquisitions in US, says Sanjiv Kaul

Indian pharmas are not seized by border tax implications as risk could be high under Trump